What is Pomalyst (Pomalidomide)
Pomalyst is a derivative of thalidomide marketed by celgene. It is anti-angiogenic and also acts as an immunomodulator.
Drug Manufacturer / Marketeer :
M/s Celgene Corporation .
1MG, 2MG, 3MG, 4MG BOTTLES
Pomalyst is indicated for multiple myeloma in patients who have received at least 2 prior therapies (including lenolidomide and bortezomib) and have disease progression on or within 60 days of completion of the last therapy.
For treatment related information, please consult your treating Physician.
Pomalyst is supplied in the following strengths:
1MG bottles of 21
1MG bottles of 100
2MG bottles of 21
2MG bottles of 100
3MG bottles of 21
3MG bottles of 100
4MG bottles of 21
4MG bottles of 100
Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Celgene Corporation.
Assistance Cell in India:
For ONCOLOGY DRUG: POMALYST (Pomalidomide) Capsules 1MG, 2MG, 3MG, 4MG price.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.